The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Recent Progress in CRISPR/Cas9 Technology
Abstract
The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system, a simple and efficient tool for genome editing, has experienced rapid progress in its technology and applicability in the past two years. Here, we review the recent advances in CRISPR/Cas9 technology and the ways that have been adopted to expand our capacity for precise genome manipulation. First, we introduce the mechanism of CRISPR/Cas9, including its biochemical and structural implications. Second, we highlight the latest improvements in the CRISPR/Cas9 system, especially Cas9 protein modifications for customization. Third, we review its current applications, in which the versatile CRISPR/Cas9 system was employed to edit the genome, epigenome, or RNA of various organisms. Although CRISPR/Cas9 allows convenient genome editing accompanied by many benefits, we should not ignore the significant ethical and biosafety concerns that it raises. Finally, we discuss the prospective applications and challenges of several promising techniques adapted from CRISPR/Cas9.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
tracrRNA is a long stretch of loops that serve as a binding scaffold for Cas-9 nuclease.
“whereas tracrRNA is a long stretch of loops that serve as a binding scaffold for Cas-9 nuclease.”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [11]
HNH domain cleaves the complementary strand, while the RuvC domain cleaves the non-complementary strand of target DNA to produce predominantly blunt-ended DSBs.
“HNH domain cleaves the complementary strand, while the RuvC domain cleaves the non-complementary strand of target DNA to produce predominantly blunt-ended DSBs.”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [11]
In prokaryotes, guide RNA targets viral DNA; in gene-editing, it can be synthetically designed by combining crRNA and tracrRNA to form sgRNA to target almost any gene sequence.
“In prokaryotes, the guide RNA is used to target viral DNA, but in the gene-editing tool, it can be synthetically designed by combining crRNA and tracrRNA to form a single guide RNA (sgRNA) in order to target almost any gene sequence supposed to be edited.11”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [11]
Guide RNA is made up of two parts: CRISPR RNA (crRNA) and trans-activating CRISPR RNA (tracrRNA).
“Guide RNA is made up of two parts, CRISPR RNA (crRNA) and trans-activating CRISPR RNA (tracrRNA).”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [11]
The designed sgRNA recognizes the target sequence in the gene of interest through complementary base pairing.
“The designed sgRNA recognizes the target sequence in the gene of interest through a complementary base pair.”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [11]
Cas-9 protein was extracted from Streptococcus pyogenes (SpCas-9) and is a large (1368 amino acids) multi-domain DNA endonuclease responsible for cleaving target DNA to form a double-stranded break.
“The Cas-9 protein, the first Cas protein used in genome editing was extracted from Streptococcus pyogenes (SpCas-9). It is a large (1368 amino acids) multi-domain DNA endonuclease responsible for cleaving the target DNA to form a double-stranded break and is called a genetic scissor.11”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [11]
The DSB is repaired by the host cellular machinery.
“Finally, the DSB is repaired by the host cellular machinery.11,15”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [11]
Guide RNA (gRNA) and Cas-9 proteins are the two essential components in CRISPR/Cas-9 system.
“Guide RNA (gRNA) and CRISPR-associated (Cas-9) proteins are the two essential components in CRISPR/Cas-9 system.”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [11]
The crRNA is 18-20 base pairs in length and specifies the target DNA by pairing with the target sequence.
“The crRNA is an 18–20 base pair in length that specifies the target DNA by pairing with the target sequence”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [11]
Citations
Cites
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“Strikingly, after 182 being fused to a repressor (such as Krüppel-associated box (KRAB) (Lawhorn et al., 183 2014)) or an activator (such as VP16 and VP64) (Gilbert et al., 2013), dCas9 can 184 block or activate gene expression, respectively (Fig.”
BackgroundWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Crystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · cited 1×
“Moreover, compared with 20-nt 229 sgRNA, the truncated RNA containing 17 or 18 nucleotides of complementarity not 230 only functions with high efficiency at target site, but also shows improved 231 specificities to minimize the off-target effect (Fu et al., 2014).”
BackgroundEngineered CRISPR-Cas9 nucleases with altered PAM specificities
Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Topkar, V. V., Nguyen, N. T., Zheng, Z., Gonzales, A. P. W., Li, Z., Peterson, R. T., Yeh, J.-R. J., et al. (2015) · Nature · doi:10.1038/nature14592 · Cited by 1,624
Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M., Ingram, J. R., & Ploegh, H. L. (2015) · Nature Biotechnology · doi:10.1038/nbt.3190 · Cited by 1,137
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
Wu, X., Scott, D. A., Kriz, A. J., Chiu, A. C., Hsu, P. D., Dadon, D. B., Cheng, A. W., Trevino, A. E., Konermann, S., Chen, S., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2889 · Cited by 944
Heritable genome editing in C. elegans via a CRISPR-Cas9 system
Friedland, A. E., Tzur, Y. B., Esvelt, K. M., Colaiácovo, M. P., Church, G. M., & Calarco, J. A. (2013) · Nature Methods · doi:10.1038/nmeth.2532 · Cited by 899
In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9
Swiech, L., Heidenreich, M., Banerjee, A., Habib, N., Li, Y., Trombetta, J., Sur, M., & Zhang, F. (2015) · Nature Biotechnology · doi:10.1038/nbt.3055 · Cited by 772 · cited 3×
“…Pten, p53 Cre-LoxP technology, hydrodynamic injection Xue et al., 2014 Brain Mecp2, Dnmt1, Dnmt3a, Dnmt3b AAV, hydrodynamic injection Swiech et al., 2015 In vitro Human hepatoma cell lines HBV cccDNA Transfection Dong et al., 2015 EPSC Tet1, Tet2, Tet3 Microinjection Wang et…”
MethodA prudent path forward for genomic engineering and germline gene modification
Baltimore, D., Berg, P., Botchan, M., Carroll, D., Charo, R. A., Church, G., Corn, J. E., Daley, G. Q., Doudna, J. A., Fenner, M., et al. (2015) · Science · doi:10.1126/science.aab1028 · Cited by 733
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
Maddalo, D., Manchado, E., Concepcion, C. P., Bonetti, C., Vidigal, J. A., Han, Y.-C., Ogrodowski, P., Crippa, A., Rekhtman, N., de Stanchina, E., et al. (2014) · Nature · doi:10.1038/nature13902 · Cited by 640
Correction of a genetic disease in mouse via use of CRISPR-Cas9
Wu, Y., Liang, D., Wang, Y., Bai, M., Tang, W., Bao, S., Yan, Z., Li, D., & Li, J. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.10.016 · Cited by 614 · cited 1×
“…Cas9 RNA/DSB Rosa26 7/7 Cytoplasm Cas9 RNA/DSB Fujita and Fujii, 2013 Hprt 17/18 Cytoplasm Cas9 RNA/DSB Crygc 13/23 Cytoplasm Cas9 px330/DSB Wu et al., 2013 Cetn1 10/17 Pronucleus Cas9 px330/DSB Mashiko et al., 2014 Cetn1 5/20 Cytoplasm Cas9 RNA/DSB Prm1 2/3 Pronucleus Cas9 px330/DSB Prm1…”
Flagged first, then by citations
Research works printed but not linked: 74
- Aida, 2015, Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice, Genome Biol., 16, 87, 10.1186/s13059-015-0653-x · DOI
- Bassett, 2015, A genome-wide CRISPR library for high-throughput genetic screening in Drosophila cells, J. Genet. Genomics, 42, 301, 10.1016/j.jgg.2015.03.011 · DOI
- Bassett, 2013, Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system, Cell Rep., 4, 220, 10.1016/j.celrep.2013.06.020 · DOI
- Bedell, 2012, In vivo genome editing using a high-efficiency TALEN system, Nature, 491, 114, 10.1038/nature11537 · DOI
- Bohannon, 2015, Biotechnology. Biologists devise invasion plan for mutations, Science, 347, 10.1126/science.347.6228.1300 · DOI
- Chang, 2013, Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos, Cell Res., 23, 465, 10.1038/cr.2013.45 · DOI
- Cho, 2014, Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases, Genome Res., 24, 132, 10.1101/gr.162339.113 · DOI · Paper page
- Cong, 2013, Multiplex genome engineering using CRISPR/Cas systems, Science, 339, 819, 10.1126/science.1231143 · DOI · Paper page
- Datsenko, 2012, Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system, Nat. Commun., 3, 945, 10.1038/ncomms1937 · DOI · Paper page
- Dickinson, 2013, Engineering the C. elegans genome using Cas9-triggered homologous recombination, Nat. Methods, 10, 1028, 10.1038/nmeth.2641 · DOI
- Dong, 2015, Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication, Antiviral Res., 118, 110, 10.1016/j.antiviral.2015.03.015 · DOI
- Fujii, 2014, Efficient generation of genome-modified mice via offset-nicking by CRISPR/Cas system, Biochem. Biophys. Res. Commun., 445, 791, 10.1016/j.bbrc.2014.01.141 · DOI
- Fujii, 2014, One-step generation of phenotype-expressing triple-knockout mice with heritable mutated alleles by the CRISPR/Cas9 system, J. Reprod. Dev., 60, 324, 10.1262/jrd.2013-139 · DOI
- Fujita, 2013, Efficient isolation of specific genomic regions and identification of associated proteins by engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) using CRISPR, Biochem. Biophys. Res. Commun., 439, 132, 10.1016/j.bbrc.2013.08.013 · DOI
- Gantz, 2015, The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations, Science, 348, 442, 10.1126/science.aaa5945 · DOI
- Gratz, 2013, Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease, Genetics, 194, 1029, 10.1534/genetics.113.152710 · DOI
- Han, 2014, Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9, RNA Biol., 11, 829, 10.4161/rna.29624 · DOI
- Heintze, 2013, A CRISPR CASe for high-throughput silencing, Front. Genet., 4, 193, 10.3389/fgene.2013.00193 · DOI
- Hemphill, 2015, Optical control of CRISPR/Cas9 gene editing, J. Am. Chem. Soc., 137, 5642, 10.1021/ja512664v · DOI
- Hilton, 2015, Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers, Nat. Biotechnol., 33, 510, 10.1038/nbt.3199 · DOI
- Hsu, 2014, Development and applications of CRISPR-Cas9 for genome engineering, Cell, 157, 1262, 10.1016/j.cell.2014.05.010 · DOI · Paper page
- Hyun, 2015, Site-directed mutagenesis in Arabidopsis thaliana using dividing tissue-targeted RGEN of the CRISPR/Cas system to generate heritable null alleles, Planta, 241, 271, 10.1007/s00425-014-2180-5 · DOI
- Jao, 2013, Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system, Proc. Natl. Acad. Sci. USA, 110, 13904, 10.1073/pnas.1308335110 · DOI · Paper page
- Jinek, 2012, A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity, Science, 337, 816, 10.1126/science.1225829 · DOI · Paper page
- Kim, 2015, Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells, Nat. Methods, 12, 237, 10.1038/nmeth.3284 · DOI · Paper page
- Larson, 2013, CRISPR interference (CRISPRi) for sequence-specific control of gene expression, Nat. Protoc., 8, 2180, 10.1038/nprot.2013.132 · DOI
- Lawhorn, 2014, Evaluation of sgRNA target sites for CRISPR-mediated repression of TP53, PLoS One, 9, e113232, 10.1371/journal.pone.0113232 · DOI
- Levy, 2015, CRISPR adaptation biases explain preference for acquisition of foreign DNA, Nature, 520, 505, 10.1038/nature14302 · DOI
- Li, 2013, Heritable gene targeting in the mouse and rat using a CRISPR-Cas system, Nat. Biotechnol., 31, 681, 10.1038/nbt.2661 · DOI
- Li, 2014, Efficient genetic manipulation of the NOD-Rag1-/-IL2RgammaC-null mouse by combining in vitro fertilization and CRISPR/Cas9 technology, Sci. Rep., 4, 5290, 10.1038/srep05290 · DOI
- Li, 2015, Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9, J. Mol. Cell Biol., 7, 284, 10.1093/jmcb/mjv016 · DOI
- Li, 2013, Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems, Nat. Biotechnol., 31, 684, 10.1038/nbt.2652 · DOI
- Liang, 2015, CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes, Protein Cell, 6, 363, 10.1007/s13238-015-0153-5 · DOI · Paper page
- Liao, 2015, Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells, Nat. Commun., 6, 6413, 10.1038/ncomms7413 · DOI
- Liao, 2015, Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells, Nat. Genet., 47, 469, 10.1038/ng.3258 · DOI
- Lin, 2014, Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery, eLife, 3, e04766, 10.7554/eLife.04766 · DOI · Paper page
- Ma, 2014, CRISPR/Cas9 mediated multiplex genome editing and heritable mutagenesis of BmKu70 in Bombyx mori, Sci. Rep., 4, 4489, 10.1038/srep04489 · DOI
- Mashiko, 2014, Feasibility for a large scale mouse mutagenesis by injecting CRISPR/Cas plasmid into zygotes, Dev. Growth Differ., 56, 122, 10.1111/dgd.12113 · DOI
- Matsunaga, 2014, Single-step generation of gene knockout-rescue system in pluripotent stem cells by promoter insertion with CRISPR/Cas9, Biochem. Biophys. Res. Commun., 444, 158, 10.1016/j.bbrc.2014.01.037 · DOI
- Nihongaki, 2015, CRISPR-Cas9-based photoactivatable transcription system, Chem. Biol., 22, 169, 10.1016/j.chembiol.2014.12.011 · DOI
- O'Connell, 2014, Programmable RNA recognition and cleavage by CRISPR/Cas9, Nature, 516, 263, 10.1038/nature13769 · DOI
- Ota, 2014, Multiple genome modifications by the CRISPR/Cas9 system in zebrafish, Genes Cells, 19, 555, 10.1111/gtc.12154 · DOI
- Parikh, 2015, Detailed phenotypic and molecular analyses of genetically modified mice generated by CRISPR-Cas9-mediated editing, PLoS One, 10, e0116484, 10.1371/journal.pone.0116484 · DOI
- Pefanis, 2015, RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity, Cell, 161, 774, 10.1016/j.cell.2015.04.034 · DOI · Paper page
- Platt, 2014, CRISPR-Cas9 knockin mice for genome editing and cancer modeling, Cell, 159, 440, 10.1016/j.cell.2014.09.014 · DOI · Paper page
- Polstein, 2015, A light-inducible CRISPR-Cas9 system for control of endogenous gene activation, Nat. Chem. Biol., 11, 198, 10.1038/nchembio.1753 · DOI
- Qin, 2015, Efficient CRISPR/Cas9-mediated genome editing in mice by zygote electroporation of nuclease, Genetics, 200, 423, 10.1534/genetics.115.176594 · DOI
- Qin, 2014, One-step generation of mice carrying gene-edited alleles by the CRISPR/Cas-mediated genome engineering with high efficiency, Transgenic Res., 23
- Ran, 2013, Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity, Cell, 154, 1380, 10.1016/j.cell.2013.08.021 · DOI · Paper page
- Ratz, 2015, CRISPR/Cas9-mediated endogenous protein tagging for RESOLFT super-resolution microscopy of living human cells, Sci. Rep., 5, 9592, 10.1038/srep09592 · DOI
- Rodriguez, 2014, AAV-CRISPR: a new therapeutic approach to nucleotide repeat diseases, Mol. Ther., 22
- Rojas-Fernandez, 2015, Rapid generation of endogenously driven transcriptional reporters in cells through CRISPR/Cas9, Sci. Rep., 5, 9811, 10.1038/srep09811 · DOI
- Sapranauskas, 2011, The Streptococcus thermophilus CRISPR/Cas system provides immunity in E. coli, Nucleic Acids Res., 39, 9275, 10.1093/nar/gkr606 · DOI
- Senis, 2014, An AAV vector toolbox for CRISPR/Cas9-mediated genome engineering, Hum. Gene Ther., 25, A24
- Seruggia, 2015, Functional validation of mouse tyrosinase non-coding regulatory DNA elements by CRISPR-Cas9-mediated mutagenesis, Nucleic Acids Res., 43, 4855, 10.1093/nar/gkv375 · DOI
- Shen, 2013, Generation of gene-modified mice via Cas9/RNA-mediated gene targeting, Cell Res., 23, 720, 10.1038/cr.2013.46 · DOI · Paper page
- Shen, 2014, Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects, Nat. Methods, 11, 399, 10.1038/nmeth.2857 · DOI · Paper page
- Singh, 2015, A mouse geneticist's practical guide to CRISPR applications, Genetics, 199, 1, 10.1534/genetics.114.169771 · DOI
- Tanenbaum, 2014, A protein-tagging system for signal amplification in gene expression and fluorescence imaging, Cell, 159, 635, 10.1016/j.cell.2014.09.039 · DOI
- Urnov, 2005, Highly efficient endogenous human gene correction using designed zinc-finger nucleases, Nature, 435, 646, 10.1038/nature03556 · DOI
- Wang, 2015, CRISPR/Cas9 nuclease cleavage combined with Gibson assembly for seamless cloning, BioTechniques, 58, 161, 10.2144/000114261 · DOI
- Wang, 2015, Egg cell-specific promoter-controlled CRISPR/Cas9 efficiently generates homozygous mutants for multiple target genes in Arabidopsis in a single generation, Genome Biol., 16, 144, 10.1186/s13059-015-0715-0 · DOI
- Westra, 2013, Type I-E CRISPR-Cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition, PLoS Genet., 9, e1003742, 10.1371/journal.pgen.1003742 · DOI
- Xu, 2015, A toolkit of CRISPR-based genome editing systems in Drosophila, J. Genet. Genomics, 42, 141, 10.1016/j.jgg.2015.02.007 · DOI
- Xue, 2014, CRISPR-mediated direct mutation of cancer genes in the mouse liver, Nature, 514, 380, 10.1038/nature13589 · DOI · Paper page
- Yang, 2013, One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering, Cell, 154, 1370, 10.1016/j.cell.2013.08.022 · DOI · Paper page
- Yin, 2014, Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype, Nat. Biotechnol., 32, 551, 10.1038/nbt.2884 · DOI · Paper page
- Yu, 2013, Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila, Genetics, 195, 289, 10.1534/genetics.113.153825 · DOI
- Zhang, 2015, Large genomic fragment deletions and insertions in mouse using CRISPR/Cas9, PLoS One, 10, e0120396, 10.1371/journal.pone.0120396 · DOI
- Zhang, 2015, Urgency to rein in the gene-editing technology, Protein Cell, 6, 10.1007/s13238-015-0161-5 · DOI
- Zhang, 2015, An efficient method for multiple site-directed mutagenesis using type IIs restriction enzymes, Anal. Biochem., 476, 26, 10.1016/j.ab.2015.01.010 · DOI
- Zhong, 2015, CRISPR-engineered mosaicism rapidly reveals that loss of Kcnj13 function in mice mimics human disease phenotypes, Sci. Rep., 5, 8366, 10.1038/srep08366 · DOI
- Zhou, 2014, One-step generation of different immunodeficient mice with multiple gene modifications by CRISPR/Cas9 mediated genome engineering, Int. J. Biochem. Cell Biol., 46, 49, 10.1016/j.biocel.2013.10.010 · DOI
- Zhu, 2014, An efficient genotyping method for genome-modified animals and human cells generated with CRISPR/Cas9 system, Sci. Rep., 4, 6420, 10.1038/srep06420 · DOI
Cited by
Sorted by citations
Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing
Mengstie, M. A., & Wondimu, B. Z. (2021) · Biologics: Targets and Therapy · doi:10.2147/btt.s326422 · Cited by 478
Metadata
- Authors
- Mei, Y., Wang, Y., Chen, H., Sun, Z. S., & Ju, X.-D.
- Venue
- Journal of Genetics and Genomics
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 43
- Issue
- 2
- Pages
- 63-75
- ISSN
- 1673-8527
- Cited by
- 148
- References
- 16
- Language
- en
- Funders
- Major State Basic Research Development Program of China (2012CB517902, 2012CB517904)
- Fundamental Research Funds for the Central Universities, (14QNJJ042)
- National Health and Family Planning Commission of China (201302002)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review